These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 24201814)

  • 1. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530).
    Huang RY; Wong MK; Tan TZ; Kuay KT; Ng AH; Chung VY; Chu YS; Matsumura N; Lai HC; Lee YF; Sim WJ; Chai C; Pietschmann E; Mori S; Low JJ; Choolani M; Thiery JP
    Cell Death Dis; 2013 Nov; 4(11):e915. PubMed ID: 24201814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).
    Huang RY; Kuay KT; Tan TZ; Asad M; Tang HM; Ng AH; Ye J; Chung VY; Thiery JP
    Oncotarget; 2015 Sep; 6(26):22098-113. PubMed ID: 26061747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis.
    Avtanski DB; Nagalingam A; Bonner MY; Arbiser JL; Saxena NK; Sharma D
    Mol Oncol; 2014 May; 8(3):565-80. PubMed ID: 24508063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
    Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
    Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
    Howe EN; Cochrane DR; Richer JK
    Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
    Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
    Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial to mesenchymal transition is associated with rapamycin resistance.
    Holder AM; Akcakanat A; Adkins F; Evans K; Chen H; Wei C; Milton DR; Li Y; Do KA; Janku F; Meric-Bernstam F
    Oncotarget; 2015 Aug; 6(23):19500-13. PubMed ID: 25944619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine lactoferrin reverses programming of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition in oral squamous cell carcinoma.
    Chea C; Miyauchi M; Inubushi T; Okamoto K; Haing S; Nguyen PT; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):142-147. PubMed ID: 30415774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM; Poryazova-Markova EG
    Folia Med (Plovdiv); 2019 Jun; 61(2):296-302. PubMed ID: 31301662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib induces epithelial-mesenchymal transition in epithelial ovarian cancer cells via regulating ZEB1 expression.
    Liu R; Zheng J; Li C; Pang Y; Zheng Q; Xu X; Liu P
    Arch Gynecol Obstet; 2015 Jun; 291(6):1361-9. PubMed ID: 25424898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
    Ko H
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness.
    Rosso M; Majem B; Devis L; Lapyckyj L; Besso MJ; Llauradó M; Abascal MF; Matos ML; Lanau L; Castellví J; Sánchez JL; Pérez Benavente A; Gil-Moreno A; Reventós J; Santamaria Margalef A; Rigau M; Vazquez-Levin MH
    PLoS One; 2017; 12(9):e0184439. PubMed ID: 28934230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
    Chaotham C; Pongrakhananon V; Sritularak B; Chanvorachote P
    Anticancer Res; 2014 Apr; 34(4):1931-8. PubMed ID: 24692728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
    Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
    J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
    Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
    Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial mesenchymal transition status is associated with anti-cancer responses towards receptor tyrosine-kinase inhibition by dovitinib in human bladder cancer cells.
    Hänze J; Henrici M; Hegele A; Hofmann R; Olbert PJ
    BMC Cancer; 2013 Dec; 13():589. PubMed ID: 24325461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinatorial treatment using targeted MEK and SRC inhibitors synergistically abrogates tumor cell growth and induces mesenchymal-epithelial transition in non-small-cell lung carcinoma.
    Chua KN; Kong LR; Sim WJ; Ng HC; Ong WR; Thiery JP; Huynh H; Goh BC
    Oncotarget; 2015 Oct; 6(30):29991-30005. PubMed ID: 26358373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Z-cad dual fluorescent sensor detects dynamic changes between the epithelial and mesenchymal cellular states.
    Toneff MJ; Sreekumar A; Tinnirello A; Hollander PD; Habib S; Li S; Ellis MJ; Xin L; Mani SA; Rosen JM
    BMC Biol; 2016 Jun; 14():47. PubMed ID: 27317311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways.
    Fang D; Chen H; Zhu JY; Wang W; Teng Y; Ding HF; Jing Q; Su SB; Huang S
    Oncogene; 2017 Mar; 36(11):1546-1558. PubMed ID: 27617576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.